Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Many Supplements Still Contain Dangerous Stimulants: StudyTapping Into TelehealthMenthol Cig Ban Didn't Spur Black Market Sales: StudyHip-Hop Loaded With Pot, Cigarette ReferencesWhite House Wants Prices in Drug Ads, But Big Pharma Fights BackMany Supplements Contain Unapproved, Dangerous Ingredients: StudyE-Cigs Continue to Spark Debate Over Health Risks/BenefitsClinical Trials Need More VolunteersGetting Your Medical Records Might Not Be EasyMost People Don't Know if They Have Genetic Risk for CancerConsumer Reports Says Warnings About Tainted Beef Don't Go Far EnoughThe Physician Assistant Will See You NowCoffee Shop Workers on Front Lines of Opioid CrisisDozens of Medical Groups Join Forces to Improve DiagnosesDoes Big Pharma Hike Prices When Meds Are in Short Supply?FDA Gets Tough on Juul, Other E-Cigarette Makers'No Documented Reason' for 1 in 3 Outpatient Opioid Rxs: StudyUrgent Care Centers Ease ER Burden in U.S.Poor Health Care Linked to 5 Million Deaths Worldwide a Year'Million Hearts' Project Aims to Prevent 1 Million Cardiac CrisesDoctor Burnout Likely to Impair CareHomelessness Takes Toll on Kids' Health Even Before They're BornFDA Warns of Dangers of Liquid Nitrogen in Food, DrinksStates Struggle With Onslaught of Opioid OD DeathsAHA: Why More Americans Are Kicking the Smoking HabitMonitoring System for Underage Tobacco Sales Falls Short: StudyHundreds of Human, Pet Homeopathy Products RecalledAHA: CPR Training at School Now Required in 38 StatesGovernment Rules Aimed at Curbing Opioid Prescriptions May Have BackfiredGut Enzyme Could Help Solve U.S. Blood ShortagesHealth Tip: Making an Emergency CallFrom Pigs to Peacocks, What's Up With Those 'Emotional-Support Animals'?Global Aid Programs Shortchange Teen Health Needs: StudyDoctors Write Fewer Opioid Scripts After Learning of Overdose DeathHow to Become an Educated PatientU.S. Murder, Suicide Rates Climbing AgainTo Boost Colon Cancer Screening, Use the MailMajority in U.S. Support Medical Pot, Think It Could Fight Opioid CrisisWhey Powder Blamed for Salmonella Tied to Ritz Crackers, Goldfish: FDAToo Few Americans Getting Screened for Cancer: CDCYou Have 11 Seconds to Tell Your Doc What's WrongFDA Warns of Deaths Tied to Tainted Synthetic PotWhere Are Opioid Painkillers Prescribed the Most?In the ICU, Patients' Relatives Often Mum About Care ConcernsResetting E-Prescriptions for Opioids Helps Curb Use: StudyHealth Tip: If You're 45 or Older, Get Screened for Colorectal CancerRed Cross Issues Nationwide Call for Blood DonationsDoctor Burnout Widespread, Helps Drive Many Medical ErrorsWarming Climate, More AC -- and More Unhealthy Smog AheadEven at 'Safe' Levels, Air Pollution May Boost Diabetes Risk
Questions and AnswersLinksBook Reviews
Related Topics

Responding to Opioid Crisis, FDA Puts More Restrictions on Imodium

HealthDay News
by -- E.J. Mundell
Updated: Jan 30th 2018

new article illustration

TUESDAY, Jan. 30, 2018 (HealthDay News) -- Increasingly, people addicted to opioid painkillers are using dangerously high doses of the diarrhea drug Imodium (loperamide), either to get high or to help ease withdrawal.

So, on Tuesday the U.S. Food and Drug Administration said it's putting new restrictions on the packaging of the medication, dubbed by some as "the poor man's methadone."

"When higher than recommended doses are taken we've received reports of serious heart problems and deaths with loperamide, particularly among people who are intentionally misusing or abusing high doses," FDA commissioner Dr. Scott Gottlieb said in an agency news release.

Because opioid abusers are using the drug in greater numbers, the FDA is requesting that makers "change the way they label and package these drugs, to stem abuse and misuse," Gottlieb said.

The FDA already slapped a warning on OTC loperamide labeling in the spring of 2017, cautioning users about the dangers of misuse.

The latest changes relate to the drugs' packaging.

Specifically, packaging of Imodium should now only "contain a limited amount of loperamide appropriate for use for short-term ['Traveler's'] diarrhea according to the product label," Gottlieb said.

For example, that might mean a package would only contain eight 2-milligram capsules of the diarrhea drug in a blister pack, the FDA said.

The new rules will also seek to eliminate the sale of loperamide in large bottles -- sales that typically occur via the Internet, Gottlieb said.

"The abuse of loperamide requires the purchase of extremely large quantities," he noted, and "today's action is intended to change how the product is packaged, to eliminate these large volume containers. We know that many of the bulk purchases of these large volumes are being made online through major online web retailers."

One busy emergency room doctor said he's witnessed the problem firsthand, and "applauds" the FDA's latest move.

"I most often encounter patients who abuse loperamide either to get high or to self-treat symptoms of opioid withdrawal," said Dr. Robert Glatter, of Lenox Hill Hospital in New York City. "Many people view it as low risk since they think it's only medicine to treat diarrhea."

"But those who abuse it to get high are gambling with their life, in essence," he said. "Simply put, escalating use may place you at risk for an overdose. An overdose of loperamide can make you stop breathing, drop your blood pressure, or even cause a fatal heart arrhythmia."

But Glatter said even more can be done to curb this new danger.

"It also starts with education, and informing parents and teens via social media platforms of the dangers of loperamide abuse," he said.

More information

There's more on the opioid abuse epidemic at the U.S. National Institute on Drug Abuse.